Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Blood|November 15, 1989
Platelet-derived growth factor concentrations in platelet-poor plasma and urine from patients with myeloproliferative disordersG M Gersuk, R Carmel, P K Pattengale
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1988
Inhibition of human natural killer cell activity by platelet-derived growth factor. II. Membrane binding studies, effects of recombinant IFN-alpha and IL-2, and lack of effect on T cell and antibody-dependent cellular cytotoxicityG M Gersuk, W C Chang, P K Pattengale
Natural Immunity and Cell Growth Regulation|January 1, 1986
Inhibition of human natural killer cell activity by platelet-derived growth factorG M Gersuk, J M Holloway, W C Chang, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1986
Correlation between allergy and persistent Epstein-Barr virus infections in chronic-active Epstein-Barr virus-infected patientsG B Olson, M N Kanaan, G M Gersuk, et al.
Scandinavian Journal of Immunology|May 1, 1991
Inhibition of human natural killer cell activity by platelet-derived growth factor (PDGF). III. Membrane binding studies and differential biological effect of recombinant PDGF isoformsG M Gersuk, B Westermark, A J Mohabeer, et al.
Natural Immunity|May 1, 1993
Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicityG M Gersuk, R Carmel, S Pattamakom, et al.
Biochemical and Biophysical Research Communications|March 17, 1997
High-affinity peptide ligands to prostate-specific antigen identified by polysome selectionG M Gersuk, M J Corey, E Corey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1997
HLA-DR-triggered inhibition of hemopoiesis involves Fas/Fas ligand interactions and is prevented by c-kit ligandJ W Lee, G M Gersuk, P A Kiener, et al.
British Journal of Haematology|October 29, 1998
A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndromeG M Gersuk, C Beckham, M R Loken, et al.
Pageof 1